218 related articles for article (PubMed ID: 29176703)
1. NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Peri S; Izumchenko E; Schubert AD; Slifker MJ; Ruth K; Serebriiskii IG; Guo T; Burtness BA; Mehra R; Ross EA; Sidransky D; Golemis EA
Nat Commun; 2017 Nov; 8(1):1772. PubMed ID: 29176703
[TBL] [Abstract][Full Text] [Related]
2.
Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
[TBL] [Abstract][Full Text] [Related]
3. The NSD family of protein methyltransferases in human cancer.
Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
[TBL] [Abstract][Full Text] [Related]
4. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
Morishita M; Mevius D; di Luccio E
BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638
[TBL] [Abstract][Full Text] [Related]
5. Disruption of
Bui N; Huang JK; Bojorquez-Gomez A; Licon K; Sanchez KS; Tang SN; Beckett AN; Wang T; Zhang W; Shen JP; Kreisberg JF; Ideker T
Mol Cancer Ther; 2018 Jul; 17(7):1585-1594. PubMed ID: 29636367
[TBL] [Abstract][Full Text] [Related]
6. Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
Gameiro SF; Ghasemi F; Zeng PYF; Mundi N; Howlett CJ; Plantinga P; Barrett JW; Nichols AC; Mymryk JS
Infect Agent Cancer; 2021 Feb; 16(1):13. PubMed ID: 33588906
[TBL] [Abstract][Full Text] [Related]
7. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
[TBL] [Abstract][Full Text] [Related]
8. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.
Ettel M; Zhao L; Schechter S; Shi J
Pathology; 2019 Jun; 51(4):392-398. PubMed ID: 31060750
[TBL] [Abstract][Full Text] [Related]
10. Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Zhang Y; Yan L; Yao W; Chen K; Xu H; Ye Z
Med Sci Monit; 2019 Jan; 25():193-239. PubMed ID: 30616239
[TBL] [Abstract][Full Text] [Related]
11. Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma.
Farhangdoost N; Horth C; Hu B; Bareke E; Chen X; Li Y; Coradin M; Garcia BA; Lu C; Majewski J
Cell Rep; 2021 Feb; 34(8):108769. PubMed ID: 33626351
[TBL] [Abstract][Full Text] [Related]
12. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.
Topchu I; Pangeni RP; Bychkov I; Miller SA; Izumchenko E; Yu J; Golemis E; Karanicolas J; Boumber Y
Cell Mol Life Sci; 2022 May; 79(6):285. PubMed ID: 35532818
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of NSD2 and NSD3 in overgrowth syndromes.
Douglas J; Coleman K; Tatton-Brown K; Hughes HE; Temple IK; Cole TR; Rahman N;
Eur J Hum Genet; 2005 Feb; 13(2):150-3. PubMed ID: 15483650
[TBL] [Abstract][Full Text] [Related]
15. Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Sun M; Chen S; Fu M
Medicine (Baltimore); 2021 Jan; 100(2):e24263. PubMed ID: 33466212
[TBL] [Abstract][Full Text] [Related]
16. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function.
Lucio-Eterovic AK; Singh MM; Gardner JE; Veerappan CS; Rice JC; Carpenter PB
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16952-7. PubMed ID: 20837538
[TBL] [Abstract][Full Text] [Related]
17. Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
Chen L; Zeng H; Zhang M; Luo Y; Ma X
Cancer Med; 2021 Jul; 10(13):4615-4628. PubMed ID: 33987946
[TBL] [Abstract][Full Text] [Related]
18. A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck.
Shete S; Liu H; Wang J; Yu R; Sturgis EM; Li G; Dahlstrom KR; Liu Z; Amos CI; Wei Q
Cancer Res; 2020 Jun; 80(12):2451-2460. PubMed ID: 32276964
[TBL] [Abstract][Full Text] [Related]
19. Nizp1, a novel multitype zinc finger protein that interacts with the NSD1 histone lysine methyltransferase through a unique C2HR motif.
Nielsen AL; Jørgensen P; Lerouge T; Cerviño M; Chambon P; Losson R
Mol Cell Biol; 2004 Jun; 24(12):5184-96. PubMed ID: 15169884
[TBL] [Abstract][Full Text] [Related]
20. Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases.
Yuan G; Ma B; Yuan W; Zhang Z; Chen P; Ding X; Feng L; Shen X; Chen S; Li G; Zhu B
J Biol Chem; 2013 Oct; 288(43):30832-42. PubMed ID: 24019522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]